1 completed, 1 terminated, 1 withdrawn. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 1, Terminated 1, Withdrawn 1 |
| Phase 3 | 1 | Completed 1 |
Follow Human Immunodeficiency Virus Infection: new trials by email Literature Review of Human Immunodeficiency Virus Infection trials Research Report on Human Immunodeficiency Virus Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Multipart, Open-label Study to Evaluate the Safety and Efficacy of ABT-450/r/ABT-267 With and Without ABT-333 Coadministered With and Without Ribavirin in Adult With Genotype 1 or 4 Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 Coinfection ABT-450/r/ABT-267, ABT-333, ribavirin - Hepatitis C Virus Infection, Human Immunodeficiency Virus Infection | Phase 2 / Phase 3 | Completed | AbbVie | 318 | 2013-08-30 | 2021-07-12 |
| A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects amdoxovir 300 mg bid, amdoxovir 500 mg bid - Human Immunodeficiency Virus Infection | Phase 2 | Withdrawn | RFS Pharma, LLC | 2013-04-01 | 2013-03-29 | |
| A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects. amdoxovir 300 mg bid, amdoxovir 500 mg bid, tenofovir DF 300 mg qd - Human Immunodeficiency Virus Infection | Phase 2 | Terminated | RFS Pharma, LLC | 2 | 2012-12-01 | 2014-11-05 |
Acquired Immunodeficiency Syndrome (3) · HIV Infections (1) · Hepatitis C (1) · Hepatitis C, Chronic (1)
Blood-Borne Infections (3) · Communicable Diseases (3) · Genital Diseases (3) · Immune System Diseases (3) · Immunologic Deficiency Syndromes (3) · Infections (3) · Lentivirus Infections (3) · RNA Virus Infections (3) · Retroviridae Infections (3) · Sexually Transmitted Diseases (3) · Sexually Transmitted Diseases, Viral (3) · Slow Virus Diseases (3) · Urogenital Diseases (3) · Virus Diseases (3) · HIV Infections (2)
BID protein, human (2) · amdoxovir (2) · Ribavirin (1) · Tenofovir (1) · dasabuvir (1) · ombitasvir (1) · paritaprevir (1)
RFS Pharma, LLC (2) · AbbVie (1)
Argentina (1)
Luz Pascual, MD MPH (2) · Rolando Viani, MD (1)